| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/14/2011 | CA2776748A1 Use of pedf in an encapsulated cell-based delivery system |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2308486A1 Pufa supplements |
| 04/13/2011 | EP2307449A1 Protein complexes and screening methods |
| 04/13/2011 | EP2307396A1 Renin inhibitors and method of use thereof |
| 04/13/2011 | EP2307055A2 Method for treating atrophic age related macular degeneration |
| 04/13/2011 | EP2307004A1 Novel treatments |
| 04/13/2011 | EP2306975A2 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015706A Imidazolidinone derivatives as 11B-HSD1 inhibitors |
| 04/13/2011 | CN102015678A Fused pyridines active as inhibitors of c-Met |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015638A Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/13/2011 | CN102015637A Novel phenylpyrrole derivative |
| 04/13/2011 | CN102015026A Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/13/2011 | CN102014957A Auris formulations for treating otic diseases and conditions |
| 04/13/2011 | CN102014920A Eye-drop preparation and use thereof |
| 04/13/2011 | CN102010454A Citicoline sodium compound and new method thereof |
| 04/13/2011 | CN102010453A Flavonol glycosides compound extracted from loropetalum chinense leaf and medicinal application thereof |
| 04/13/2011 | CN102010324A Aspirin-triggered lipid mediators |
| 04/13/2011 | CN102008679A Traditional Chinese medicine composition for treating pinkeye |
| 04/13/2011 | CN102008649A Traditional Chinese medicine composition for treating retinal periphlebitis |
| 04/13/2011 | CN102008623A Traditional Chinese medicine preparation for treating Meniere's syndrome |
| 04/13/2011 | CN102008609A Drug for curing eye diseases |
| 04/13/2011 | CN102008596A Chinese medicine eye compressing bag for treating myopic eye and using method thereof |
| 04/13/2011 | CN102008548A Fire clearing tea for treating pinkeye |
| 04/13/2011 | CN102008526A Nasal obstruction powder for treating trichiasis |
| 04/13/2011 | CN102008488A Triamcinolone acetonide ophthalmic preparation and preparation method thereof |
| 04/13/2011 | CN102008474A Application of nitidine chloride to preparation of medicament for resisting autoimmunity disease and graft versus host disease |
| 04/13/2011 | CN102008470A Compound preparation and use thereof for preventing and treating noise induced hearing damage |
| 04/13/2011 | CN102008468A Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
| 04/13/2011 | CN102008439A Curcumin coated liposome preparation and preparation method thereof |
| 04/13/2011 | CN102008437A Rapamycin microemulsion injection for eyes and preparation method and application thereof |
| 04/13/2011 | CN102008428A Ophthalmic depot formulations for periocular or subconjunctival administration |
| 04/13/2011 | CN102008427A Latanoprost ophthalmic in situ slow release gel |
| 04/13/2011 | CN101658491B Amnion eye drops for curing cornea alkali burn |
| 04/13/2011 | CN101585813B Prepartion method of N-acetyl-L-carnosine |
| 04/13/2011 | CN101444496B Compounds for the treatment of metabolic disorders |
| 04/13/2011 | CN101405009B Ophthalmic composition comprising xanthan gum and glucose |
| 04/13/2011 | CN101385770B Blueberry chrysanthemum capsules and preparation method thereof |
| 04/13/2011 | CN101212960B Eye drop preparation comprising xanthan gum and terpenoid |
| 04/13/2011 | CN101146516B Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 04/13/2011 | CN101074189B Styrene acid derivative and use in preparation of various blood-vessels target agent medicine |
| 04/13/2011 | CN101057966B Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor |
| 04/12/2011 | US7923469 Compositions including vitamin-based surfactants and methods for using same |
| 04/12/2011 | US7923441 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 04/12/2011 | CA2474875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2,-a]pyrimidin-5(1h)-one derivatives |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/12/2011 | CA2396542C Composition promoting lacrimal secretion |
| 04/07/2011 | WO2011041642A1 Microparticle compositions and methods for treating age-related macular degeneration |
| 04/07/2011 | WO2011040572A1 Ophthalmic composition |
| 04/07/2011 | WO2011040564A1 Ophthalmic agent comprising specific peptide compound as active ingredient |
| 04/07/2011 | WO2011040433A1 Eye drops |
| 04/07/2011 | WO2011040432A1 Eye wash agent |
| 04/07/2011 | WO2011040071A1 Antioxidant composition |
| 04/07/2011 | WO2011040070A1 Oral composition for alleviation of ultraviolet radiation-induced damage |
| 04/07/2011 | WO2011040004A1 Novel phenylpyridine derivative and medicinal agent comprising same |
| 04/07/2011 | WO2011038485A1 Crosslinked hydrogels and related method of preparation |
| 04/07/2011 | US20110082221 In situ gelling systems as sustained delivery for front of eye |
| 04/07/2011 | US20110082212 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 04/07/2011 | US20110082211 Method for treating tinnitus aureum |
| 04/07/2011 | US20110082200 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 04/07/2011 | US20110082184 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 04/07/2011 | US20110082181 Compounds as Lysophosphatidic Acid Receptor Antagonists |
| 04/07/2011 | US20110082153 Gamma secretase modulators |
| 04/07/2011 | US20110082149 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110082145 Olopatadine compositions and uses thereof |
| 04/07/2011 | US20110082131 Triazole derivatives useful as axl inhibitors |
| 04/07/2011 | US20110082129 Organic compounds |
| 04/07/2011 | US20110082128 In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts |
| 04/07/2011 | US20110082125 Topical Ophthalmic or Otic Solution Formulations Containing Moxifloxacin Hydrocholoride and Dexamethasone Phosphate |
| 04/07/2011 | US20110082092 Interfering rna delivery system and uses thereof |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110081428 Use of thioflavin-like compounds to increase life span and/or health span |
| 04/07/2011 | US20110081393 Cooling sensation agent composition, sensory stimulation agent composition and use of the same |
| 04/07/2011 | US20110081342 Anti-vegf antibodies |
| 04/07/2011 | CA2776472A1 Microparticle compositions and methods for treating age-related macular degeneration |
| 04/07/2011 | CA2776366A1 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 04/07/2011 | CA2775670A1 Crosslinked hydrogels and related method of preparation |
| 04/07/2011 | CA2768968A1 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305308A1 Remedies for diseases to be applied to eye |
| 04/06/2011 | EP2305298A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305297A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305268A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 04/06/2011 | EP2305261A1 Methods of manufacturing intraocular implants of alpha-2 adrenergic receptor agonists |
| 04/06/2011 | EP2305239A1 Retinal neuroprotection by ionic channel inhibitors regulated by the SUR subunit |
| 04/06/2011 | EP2305233A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |